(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers oral abstract session. Dr. Thomas Powles presented 3.5-year follow-up data ...
US FDA approves AstraZeneca’s Imfinzi for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer: Cambridge, UK Saturday, May 30, 2026, 13:00 Hrs [IST] AstraZene ...
Apollo Hospitals Chennai, a leader in robotic-assisted cancer care, has performed the world's first Video Endoscopic Inguinal Lymphadenectomy (VEIL) using the Hugo Robotic-Assisted Surgery (RAS) ...
AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
The FDA approved durvalumab (Imfinzi) in combination with bacillus Calmette-Guérin (BCG) for adults with BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC). The approval was based on ...
Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...
AstraZeneca has fired another volley in its bladder cancer competition with Merck’s Keytruda, with the FDA on Thursday ...
The FDA has approved durvalumab (Imfinzi, AstraZeneca) in combination with Bacillus Calmette-Guerin (BCG) for adults with BCG-naive, high-risk non-muscle-invasive bladder cancer (NIMBC). Approval was ...
The FDA has approved an immunotherapy combination therapy for adult patients with Bacillus Calmette-Guérin-naive, high-risk ...
Gross hematuria in a younger adult prompted rapid urologic evaluation, underscoring that bladder cancer can present before ...
Apollo Hospitals Chennai pioneers robotic cancer surgery, performing minimally invasive lymph node removal for enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results